0 Σχόλια
0 Μοιράστηκε
236 Views
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Ροή Δημοσιεύσεων
- ΑΝΑΚΆΛΥΨΕ
-
Σελίδες
-
Ομάδες
-
Blogs
-
Forum
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Breast Cancer Drugs Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030According to the latest report published by Data Bridge Market Research, the Breast Cancer Drugs Market Data Bridge Market Research analyzes that the global breast cancer drugs market is expected to reach USD 55,996.57 million by 2030 from USD 30,247.54 million in 2022, growing at a CAGR of 8.2% during the forecast period of 2023 to 2030. All the statistical data including...0 Σχόλια 0 Μοιράστηκε 207 Views
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views
-
Epidermal Growth Factor Receptor Inhibitor Market Global Industry Overview and ForecastThe global Epidermal Growth Factor Receptor (EGFR) inhibitor industry is witnessing substantial momentum due to the increasing prevalence of cancer, growing adoption of targeted therapies, and advancements in precision medicine. The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 Billion by 2034 from US$ 15.92 Billion in 2025. The market is estimated to...0 Σχόλια 0 Μοιράστηκε 425 Views
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views
-
Hematology Oncology Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033According to the latest report published by Data Bridge Market Research, the Hematology Oncology Market The global hematology oncology market size was valued at USD 10.98 billion in 2025 and is expected to reach USD 20.02 billion by 2033, at a CAGR of 7.80% during the forecast period The wide ranging Hematology Oncology Market report provides an...0 Σχόλια 0 Μοιράστηκε 351 Views
-
Hematology Oncology Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033According to the latest report published by Data Bridge Market Research, the Hematology Oncology Market The global hematology oncology market size was valued at USD 10.98 billion in 2025 and is expected to reach USD 20.02 billion by 2033, at a CAGR of 7.80% during the forecast period The wide ranging Hematology Oncology Market report provides an...0 Σχόλια 0 Μοιράστηκε 367 Views
-
TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views
-
United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...0 Σχόλια 0 Μοιράστηκε 125 Views
-
Uterine Carcinosarcoma Market Size, Share and Trends Forecast to 2029According to the latest report published by Data Bridge Market Research, the Uterine Carcinosarcoma Market Data Bridge Market Research analyses a growth rate in the global uterine carcinosarcoma market in the forecast period 2022-2029. The expected CAGR of global uterine carcinosarcoma market is tend to be around 6.50% in the mentioned forecast period. The market was valued at...0 Σχόλια 0 Μοιράστηκε 233 Views
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)